Register entry

MAHI DRUGS PRIVATE LIMITED

Registered sites
1
Drug products
10
Live patents
0
Countries
1
Base
India
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Analytical testingActive ingredient (API) manufactureLabellingPackaging
Sites

Facilities

1
SiteLocationOperationsFEI
MAHI DRUGS PRIVATE LIMITEDAnakapalliIndiaAnalytical testing, Active ingredient (API) manufacture, Labelling, Packaging3019853340
Catalogue

Marketed products

10

Showing 10 of 10.

BrandGeneric nameFormCategory
-AlbendazolePOWDERBULK INGREDIENT
-BrinzolamidePOWDERBULK INGREDIENT
-Fosaprepitant DimegluminePOWDERBULK INGREDIENT
-Fosphenytoin SodiumPOWDERBULK INGREDIENT
-Hydroxyzine HydrochloridePOWDERBULK INGREDIENT
-PI 301POWDERBULK INGREDIENT
-Squaric Acid Butyl EsterPOWDERBULK INGREDIENT
-Squaric Acid Dibutyl EsterLIQUIDBULK INGREDIENT
-Tiagabine HydrochloridePOWDERBULK INGREDIENT
-Trazodone HydrochloridePOWDERBULK INGREDIENT
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.